Nuclear Radiology: Page 41

EANM announces 2017 board members
By AuntMinnieEurope.com staff writers
In a letter from President Dr. Arturo Chiti, the European Association of Nuclear Medicine (EANM) announced its board members for 2017.
December 13, 2016
Hermes launches new liver analysis software
By AuntMinnieEurope.com staff writers
Swedish nuclear medicine software developer Hermes Medical Solutions has released its Remnant liver analysis software to bring surgical planning to its hybrid viewer platform.
November 28, 2016
Hermes expands North America executive team
By AuntMinnieEurope.com staff writers
Swedish nuclear medicine software developer Hermes Medical Solutions said it is expanding its operations in North America, welcoming new leaders in the process.
November 17, 2016
Segula V plans expansion for molecular firm Hermes
By AuntMinnieEurope.com staff writers
Following its acquisition of Swedish nuclear medicine firm Hermes Medical Solutions in April 2016, private equity partnership Segulah V said it will continue to increase its investment in the firm, both in development and operations, to ensure its success in molecular imaging.
November 14, 2016
Eckert & Ziegler posts 9-month financial results
By AuntMinnieEurope.com staff writers
Isotope technology firm Eckert & Ziegler has posted financial results for the nine-month period ending 30 September.
November 3, 2016
EANM opens ESMIT 2017 registration
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) has opened registration for its European School of Multimodality Imaging and Therapy (ESMIT) Spring School 2017, to be held 31 March to 2 April in Groningen, the Netherlands.
November 3, 2016
Nuclear medicine/radiopharma market primed for growth
By AuntMinnieEurope.com staff writers
The global nuclear medicine and radiopharmaceuticals market generated $4.7 billion U.S. (4.3 billion euros) in revenues in 2016 and is expected to grow at a compound annual growth rate of 9.3% to reach $7.3 billion (6.7 billion euros) by 2021, according to a new report from MarketsandMarkets.
October 25, 2016
Blue Earth PET radiotracer IDs prostate cancer recurrence
By AuntMinnieEurope.com staff writers
Radiopharmaceutical developer Blue Earth Diagnostics is highlighting results from a phase III clinical trial of its Axumin (fluciclovine F-18) PET radiopharmaceutical agent indicating a 68% detection rate for prostate cancer recurrence.
October 23, 2016
CMR Naviscan highlights PEM study
By AuntMinnieEurope.com staff writers
PET developer Compañía Mexicana de Radiología (CMR) Naviscan is highlighting clinical results regarding positron emission mammography (PEM) published September 2 in European Radiology.
October 20, 2016
Philips collaborates with FluoroPharma for CardioPET study
By AuntMinnieEurope.com staff writers
Philips Healthcare said it has collaborated with radiopharmaceutical developer FluoroPharma Medical on a phase II clinical trial for FluoroPharma's CardioPET radiopharmaceutical.
October 18, 2016
MILabs launches micron-resolution SPECT at EANM
By AuntMinnieEurope.com staff writers
Preclinical imaging developer MILabs has launched a new micron-resolution SPECT unit for tissue samples at the European Association of Nuclear Medicine (EANM) congress in Barcelona, Spain.
October 16, 2016
Kromek announces new contracts worth 2.7M euros
By AuntMinnieEurope.com staff writers
Radiation detection technology firm Kromek has received new contracts worth more than 2.7 million euros, including agreements with the U.S. Defense Threat Reduction Agency and the U.K. Ministry of Defense.
October 16, 2016
Previous Page
Page 41 of 90
Next Page